Bautista, F., Paoletti, X., Rubino, J., Brard, C., Rezai, K., Nebchi, S., Andre, N., Aerts, I., De Carli, E., van Eijkelenburg, N., Thebaud, E., Corradini, N., Defachelles, A., Ducassou, S., Morscher, R. J., Vassal, G., & Geoerger, B. (2021). phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial. Journal of clinical oncology, 39(32), 3546–3560. http://access.bl.uk/ark:/81055/vdc_100150611153.0x000037